HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerhard Krammer Selected Research

lumiracoxib (prexige)

9/2008A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
8/2008Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial.
8/2008A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen.
5/2008Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
1/2008Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial.
7/2007Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.
8/2005Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
8/2004Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
8/2004Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerhard Krammer Research Topics

Disease

6Osteoarthritis
09/2008 - 08/2004
4Body Weight (Weight, Body)
01/2021 - 10/2018
4Pain (Aches)
03/2016 - 01/2008
4Arthritis (Polyarthritis)
08/2008 - 08/2004
3Rheumatoid Arthritis
03/2016 - 08/2005
3Infections
03/2016 - 07/2011
3Gouty Arthritis
12/2013 - 07/2011
3Inflammation (Inflammations)
11/2012 - 05/2008
3Ulcer
05/2008 - 08/2004
2Hypertension (High Blood Pressure)
08/2008 - 08/2008
1Hypertrophy
01/2020
1Taste Disorders (Taste Disorder)
03/2018
1Ulcerative Colitis
01/2013
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2011
1Colitis
11/2011
1Fatigue
07/2011
1Chronic Disease (Chronic Diseases)
07/2011
1Edema (Dropsy)
08/2008
1Heart Failure
08/2008
1Stroke (Strokes)
08/2005
1Myocardial Infarction
08/2004

Drug/Important Bio-Agent (IBA)

9lumiracoxib (prexige)IBA
09/2008 - 08/2004
7Ibuprofen (Motrin)FDA LinkGeneric
09/2008 - 08/2004
6Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2008 - 08/2004
6Naproxen (Naprosyn)FDA LinkGeneric
09/2008 - 08/2004
4Monoclonal AntibodiesIBA
03/2016 - 07/2011
4canakinumabFDA Link
12/2013 - 07/2011
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2008 - 08/2005
3InterleukinsIBA
12/2013 - 07/2011
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2007 - 08/2004
2Epoxy Compounds (Epoxides)IBA
01/2021 - 01/2020
2C-Reactive ProteinIBA
03/2016 - 12/2013
2ColchicineFDA LinkGeneric
11/2012 - 07/2011
2rofecoxib (Vioxx)FDA Link
09/2008 - 08/2005
2Celecoxib (Celebrex)FDA Link
01/2008 - 08/2005
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2004 - 08/2004
1Norisoprenoids (Irones)IBA
01/2021
1caryophylleneIBA
01/2020
1CholesterolIBA
10/2018
1myrceneIBA
10/2018
1HesperidinIBA
03/2018
1secukinumabIBA
03/2016
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
12/2013
1Serum Amyloid A Protein (Serum Amyloid A)IBA
12/2013
1ORALIT (ORS)IBA
11/2012
1Drinking WaterIBA
11/2011
1Anthocyanins (Anthocyanin)IBA
11/2011
1SodiumIBA
11/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2011
1CytokinesIBA
11/2011
1Therapeutic UsesIBA
11/2011
1Uric Acid (Urate)IBA
07/2011
1Allopurinol (Remid)FDA LinkGeneric
07/2011
1Antihypertensive Agents (Antihypertensives)IBA
08/2008
1Capsules (Microcapsules)IBA
05/2008
1Lactulose (Duphalac)FDA LinkGeneric
05/2008
1RhamnoseIBA
05/2008
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
05/2008
1Diclofenac (SR 38)FDA LinkGeneric
08/2005

Therapy/Procedure

2Therapeutics
01/2013 - 07/2011
1Oral Administration
11/2011
1Analgesia
01/2008